RBC Capital raised the firm’s price target on Albemarle (ALB) to $245 from $216 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Specialty Chemicals names. The firm continues to see company-specific items as major drivers for improvement in 2026, with a preference for names with minimal impact from Middle East conflict and higher oil cost, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Albemarle price target raised to $245 from $210 at Truist
- Albemarle downgraded to Neutral from Buy at Rothschild & Co Redburn
- Albemarle price target raised to $225 from $190 at BofA
- Albemarle price target raised to $210 from $190 at Citi
- Albemarle, Onto, Qorvo, JPMorgan, Skyworks Trending With Analysts